Acthera Therapeutics AG
PrivateLast Round
Grant
Jun 23, 2022
Total Funding Raised
$6.01M
Company Overview
Acthera Therapeutics AG operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Grant round in June 2022.
Acthera Therapeutics AG is a biotechnology company that develops mechanosensitive hard-shelled liposomes for the targeted and controlled delivery of therapeutic payloads to treat acute cardiovascular conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acthera Therapeutics AG Comparables
Compare Acthera Therapeutics AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thermosome GmbH | 71% | |
| LIPOSOMA B.V. | 66% | |
| TargED Biopharmaceuticals | 57% |
For institutional investors. Book with your work email.
Acthera Therapeutics AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 23, 2022 | ||||
| Seed | Jul 2, 2021 |
For institutional investors. Book with your work email.
Acthera Therapeutics AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Verve Ventures | Seed |
| W.A. de Vigier Foundation | Grant |
| BERNINA BioInvest AG | Seed |
Acthera Therapeutics AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Acthera Therapeutics AG's valuation, stock price, and market status.
Is Acthera Therapeutics AG a public or private company?
Acthera Therapeutics AG is a private company.
What is the current stock price of Acthera Therapeutics AG?
Acthera Therapeutics AG is a private company, so its shares have no public market price. Caplight tracks Acthera Therapeutics AG's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Acthera Therapeutics AG worth (valuation)?
Valuation information for Acthera Therapeutics AG is not publicly available.
Can I buy Acthera Therapeutics AG stock?
Acthera Therapeutics AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Acthera Therapeutics AG's last funding round?
Acthera Therapeutics AG's most recent funding round was Grant on June 23, 2022.
Who are the main investors in Acthera Therapeutics AG?
Key investors in Acthera Therapeutics AG include Verve Ventures, W.A. de Vigier Foundation, BERNINA BioInvest AG.
Will Acthera Therapeutics AG IPO soon?
No public IPO plans have been announced for Acthera Therapeutics AG.
How can I track Acthera Therapeutics AG secondary market activity?
Caplight tracks bids, offers, and trades in Acthera Therapeutics AG's shares on secondary markets.